{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-10-27T12:23:51.425288+00:00",
  "news": [
    {
      "title": "Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030 - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxONnhWcExxNnhCV2I3RUtTOWFuWmJrZmNUN2pSQTFHVi1fQmtGcHdIcHltWXlkX0t4RnBrTVhwejJrVFVvS1hld0Fzd0Q5LXFGSG9kZjRiaGREUUhHNUNJTGJ5eklmOFhEeE1iS25NVm44NE43TlNxNXc4RnN5SW1jZXZoUkRuOWFsTmVKMlRyakpBUG9zOE40NQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxONnhWcExxNnhCV2I3RUtTOWFuWmJrZmNUN2pSQTFHVi1fQmtGcHdIcHltWXlkX0t4RnBrTVhwejJrVFVvS1hld0Fzd0Q5LXFGSG9kZjRiaGREUUhHNUNJTGJ5eklmOFhEeE1iS25NVm44NE43TlNxNXc4RnN5SW1jZXZoUkRuOWFsTmVKMlRyakpBUG9zOE40NQ?oc=5\" target=\"_blank\">Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-10-27T09:43:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Bank of America Securities Remains Bullish on Vertex Pharmaceuticals Incorporated (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPY3dzUk81WGYwYVIwaWdEQnJ2Z28wdklTeDRienhrRTIzZTV6TVhzNXpHWS1uVVVwZGFvU0xpM2dwMGNTSmhFQzRlRFhmYVpUSUNmM2RKUndoaDNWc1RVU0NWMm53V1QwcXRqbkxzVERud1pTdzh0V3RRdzh0YXZfazdBYVo5TC1CUFlLanVR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxPY3dzUk81WGYwYVIwaWdEQnJ2Z28wdklTeDRienhrRTIzZTV6TVhzNXpHWS1uVVVwZGFvU0xpM2dwMGNTSmhFQzRlRFhmYVpUSUNmM2RKUndoaDNWc1RVU0NWMm53V1QwcXRqbkxzVERud1pTdzh0V3RRdzh0YXZfazdBYVo5TC1CUFlLanVR?oc=5\" target=\"_blank\">Bank of America Securities Remains Bullish on Vertex Pharmaceuticals Incorporated (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-23T02:35:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals Stock Forecast: Where Analysts See the Stock Going by 2027 - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPZjZ4Ny1TWnpCakJrLW9lLWVOUFQyeW9JYzI5UHFUcW5MaDBfa0laQ2FpX0Q1QkFVaGRMSDFDSGltN0hRT1FYNF9RSEFuVmt5bkZZUDIzMDlnQU9mLVdkUjRmZ1pCYy1mYTZzaFFDT2NzNTl5NEpQRHl6S3ZOZDJPRGFIbHB1OTVHZ19yWkotY3pNQzd4aHM1ZmlIcmJta2RaYWZ3M2JndmNUdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPZjZ4Ny1TWnpCakJrLW9lLWVOUFQyeW9JYzI5UHFUcW5MaDBfa0laQ2FpX0Q1QkFVaGRMSDFDSGltN0hRT1FYNF9RSEFuVmt5bkZZUDIzMDlnQU9mLVdkUjRmZ1pCYy1mYTZzaFFDT2NzNTl5NEpQRHl6S3ZOZDJPRGFIbHB1OTVHZ19yWkotY3pNQzd4aHM1ZmlIcmJta2RaYWZ3M2JndmNUdw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock Forecast: Where Analysts See the Stock Going by 2027</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-10-25T07:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex’s quest for a breakthrough in Type 1 diabetes - PharmaVoice",
      "link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNRHp0TUJXVlNnamdTNXNkUmJTOHNsRm1wVHU4d1FQMnktaTNKMFNnbEZKcEp2U3UtQXpMWmcxdXlDS3hjV0EyVWdTdkVDRHNqSDVFRkZnbFRKUTRnSG1qeEIxejZIaHh0NHVPemwtVW8zY2xTOWpRbkdSMi1qWTJzQnJuQ2s1S2tLOEJSQk9Vd2EwUWJZb3ZKN1RfNTVLS0RR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxNRHp0TUJXVlNnamdTNXNkUmJTOHNsRm1wVHU4d1FQMnktaTNKMFNnbEZKcEp2U3UtQXpMWmcxdXlDS3hjV0EyVWdTdkVDRHNqSDVFRkZnbFRKUTRnSG1qeEIxejZIaHh0NHVPemwtVW8zY2xTOWpRbkdSMi1qWTJzQnJuQ2s1S2tLOEJSQk9Vd2EwUWJZb3ZKN1RfNTVLS0RR?oc=5\" target=\"_blank\">Vertex’s quest for a breakthrough in Type 1 diabetes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PharmaVoice</font>",
      "published": "2025-10-08T07:00:00+00:00",
      "source": "PharmaVoice"
    },
    {
      "title": "CF buyers club aims to grow access to Vertex's Trikafta through trade-policy workaround - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOcGl1VW1CbE5Oc1h2cEhKNEU0cXhqX2sxdnhUVlRfZFROT1JXc2dDRzJ1M3JPckh4UzZWblFOeE5lNmhpQld5bDhXYTJvNGlXaTNQMjdXOVhSeS1jU045TzRkYV9WWnZaRnR1R1ppamxhbG14cjY0V2FOdzNRcGRkVGROcnJLYjQtRTBnUm5zd0gzY3BYYmtZVGRQLWlCVmZKWWk3UHdBYWZPZDNjOEhsZlVtSUlmQkxDUGo1czlwSlhBN0RNNXhV?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxOcGl1VW1CbE5Oc1h2cEhKNEU0cXhqX2sxdnhUVlRfZFROT1JXc2dDRzJ1M3JPckh4UzZWblFOeE5lNmhpQld5bDhXYTJvNGlXaTNQMjdXOVhSeS1jU045TzRkYV9WWnZaRnR1R1ppamxhbG14cjY0V2FOdzNRcGRkVGROcnJLYjQtRTBnUm5zd0gzY3BYYmtZVGRQLWlCVmZKWWk3UHdBYWZPZDNjOEhsZlVtSUlmQkxDUGo1czlwSlhBN0RNNXhV?oc=5\" target=\"_blank\">CF buyers club aims to grow access to Vertex's Trikafta through trade-policy workaround</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-10-24T15:17:31+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Home - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5\" target=\"_blank\">Home</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-06-02T15:34:51+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Pharmalittle: We're reading about a GSK drug's comeback, a buyer's club for a Vertex drug, and more - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPNlRkQjgteGpjdzZkWXdFckxMTTlFX3ljU3duSHNIb2JMZ2xuNFdDSklRSDRWdEpPVGtlNElVcU8yUUxTMTkxcXJ6dDMzRVcyMlBPUW5EeDA3LVRBam1iaFktMjdUOTFXU2ttQmVQNXpSZG9IdHljcGVxM0cxS1VvV1RZajZZY0xDSDYzVlhTU2x1VFNrbUE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxPNlRkQjgteGpjdzZkWXdFckxMTTlFX3ljU3duSHNIb2JMZ2xuNFdDSklRSDRWdEpPVGtlNElVcU8yUUxTMTkxcXJ6dDMzRVcyMlBPUW5EeDA3LVRBam1iaFktMjdUOTFXU2ttQmVQNXpSZG9IdHljcGVxM0cxS1VvV1RZajZZY0xDSDYzVlhTU2x1VFNrbUE?oc=5\" target=\"_blank\">Pharmalittle: We're reading about a GSK drug's comeback, a buyer's club for a Vertex drug, and more</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-10-24T13:58:02+00:00",
      "source": "statnews.com"
    },
    {
      "title": "TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals - Time Magazine",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5\" target=\"_blank\">TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Time Magazine</font>",
      "published": "2025-06-26T07:00:00+00:00",
      "source": "Time Magazine"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals: Strong Growth Potential with Promising Product Launches and Robust Pipeline - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxNYTltcjN3Z2J3czZWRkNXWFMyQm10SzdfU0dtajd4UkJMRFZVOTlkTVpCTC1JMnpnUThEaTZSVnFFd3NZT3Z2NVFjM1ctTEhyOTJFa0pLdUc1QmxlVkUzeXljQnFKNnBiVDU5N2ZENXFfYnh6azR3TkNKRDg4QktEeDBNVFpHVDc1bVNnVVk1eVZIc0tMTEhNV2JUSWRZYlZyWTVxdmtyWE1pT0ZxM0poLXViTGRjc0RGenhoSkFZTDg0d1VfdVIzYWpnZ0dWVWRsX3puLWJEZUN6Q0tK?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3AFBVV95cUxNYTltcjN3Z2J3czZWRkNXWFMyQm10SzdfU0dtajd4UkJMRFZVOTlkTVpCTC1JMnpnUThEaTZSVnFFd3NZT3Z2NVFjM1ctTEhyOTJFa0pLdUc1QmxlVkUzeXljQnFKNnBiVDU5N2ZENXFfYnh6azR3TkNKRDg4QktEeDBNVFpHVDc1bVNnVVk1eVZIc0tMTEhNV2JUSWRZYlZyWTVxdmtyWE1pT0ZxM0poLXViTGRjc0RGenhoSkFZTDg0d1VfdVIzYWpnZ0dWVWRsX3puLWJEZUN6Q0tK?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Strong Growth Potential with Promising Product Launches and Robust Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    },
    {
      "title": "Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOQzRYUXFRSkhaTzlvRWhZSDFkVWs5RlhYNUV4TURuR2NmNFB6U2tvZEpYdFpwZ2VWUk5TekNMQ2tFMUdVS29FMWJBeXI4MW1zcFQzYk83MFRoOEFIdlA4QjJBLWJMZllBazJJX0JYbDdvVXJEZGJiYklTS09YUkNEXzJUbWxmVnZWLUdDcG8yeDJWb2xGcnFqSEwybW9HYWdqWV93SElPS1BqZGFMc0s4ZzFYcjhGaXV1?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOQzRYUXFRSkhaTzlvRWhZSDFkVWs5RlhYNUV4TURuR2NmNFB6U2tvZEpYdFpwZ2VWUk5TekNMQ2tFMUdVS29FMWJBeXI4MW1zcFQzYk83MFRoOEFIdlA4QjJBLWJMZllBazJJX0JYbDdvVXJEZGJiYklTS09YUkNEXzJUbWxmVnZWLUdDcG8yeDJWb2xGcnFqSEwybW9HYWdqWV93SElPS1BqZGFMc0s4ZzFYcjhGaXV1?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-09-24T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-10-24",
      "close": 421.3900146484375
    },
    "history": [
      {
        "date": "2025-10-16",
        "close": 408.6099853515625
      },
      {
        "date": "2025-10-17",
        "close": 416.80999755859375
      },
      {
        "date": "2025-10-20",
        "close": 419.1000061035156
      },
      {
        "date": "2025-10-21",
        "close": 426.2699890136719
      },
      {
        "date": "2025-10-22",
        "close": 426.44000244140625
      },
      {
        "date": "2025-10-23",
        "close": 422.6300048828125
      },
      {
        "date": "2025-10-24",
        "close": 421.3900146484375
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}